Patient Case 1: A Sixty-Five-Year-Old Man With Prostate Cancer
Neal Shore, MD, FACS, discusses the progress of a 65-year-old patient with mCRPC through various treatments and evaluation for Lutetium-177 therapy based on his PSMA PET scan and MRI.
Related Content
